Head circumference trajectory in children with perinatal stroke.


Journal

Journal of child neurology
ISSN: 1708-8283
Titre abrégé: J Child Neurol
Pays: United States
ID NLM: 8606714

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 9 3 2021
medline: 13 1 2022
entrez: 8 3 2021
Statut: ppublish

Résumé

Perinatal stroke is a leading cause of hemiparetic cerebral palsy and lifelong disability. Neurodevelopmental outcomes are difficult to predict and markers of long-term poor outcome continue to be investigated. Deceleration in growth of head circumference has been associated with worse developmental outcomes in neonatal brain injury. We hypothesized that perinatal stroke would result in decreased rates of head growth during childhood that would be associated with worse developmental outcomes. Patients with magnetic resonance imaging (MRI)-confirmed neonatal arterial ischemic stroke and arterial presumed perinatal ischemic stroke were identified from a population-based research cohort (Alberta Perinatal Stroke Project). Demographics and occipital-frontal circumference data were collected from medical records. Head growth was compared to typically developing control charts using a 2-tailed Three hundred fifteen occipital-frontal head circumference measurements were collected from 102 patients (48 female, 54 male), over a median of 3.2 years (standard deviation = 5.18, range = 0-18.3). After 3 months for female patients and 1 year for male patients, occipital-frontal head circumference deviated and remained below normal growth trajectories ( Head growth deceleration is observed in children with perinatal arterial ischemic stroke and is associated with poor outcome. Head circumference may be a tool to alert clinicians to the potential of abnormal neurologic outcome.

Sections du résumé

BACKGROUND
Perinatal stroke is a leading cause of hemiparetic cerebral palsy and lifelong disability. Neurodevelopmental outcomes are difficult to predict and markers of long-term poor outcome continue to be investigated. Deceleration in growth of head circumference has been associated with worse developmental outcomes in neonatal brain injury. We hypothesized that perinatal stroke would result in decreased rates of head growth during childhood that would be associated with worse developmental outcomes.
METHODS
Patients with magnetic resonance imaging (MRI)-confirmed neonatal arterial ischemic stroke and arterial presumed perinatal ischemic stroke were identified from a population-based research cohort (Alberta Perinatal Stroke Project). Demographics and occipital-frontal circumference data were collected from medical records. Head growth was compared to typically developing control charts using a 2-tailed
RESULTS
Three hundred fifteen occipital-frontal head circumference measurements were collected from 102 patients (48 female, 54 male), over a median of 3.2 years (standard deviation = 5.18, range = 0-18.3). After 3 months for female patients and 1 year for male patients, occipital-frontal head circumference deviated and remained below normal growth trajectories (
CONCLUSION
Head growth deceleration is observed in children with perinatal arterial ischemic stroke and is associated with poor outcome. Head circumference may be a tool to alert clinicians to the potential of abnormal neurologic outcome.

Identifiants

pubmed: 33683972
doi: 10.1177/0883073821996103
pmc: PMC8255504
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

680-685

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Neuroimage Clin. 2019;21:101660
pubmed: 30639178
Dev Med Child Neurol. 2005 Nov;47(11):766-70
pubmed: 16225741
Lancet. 1981 Aug 8;2(8241):297-9
pubmed: 6114335
Acta Paediatr. 2000 Feb;89(2):198-202
pubmed: 10709891
J Child Neurol. 2011 Sep;26(9):1154-62
pubmed: 21670391
JAMA Pediatr. 2017 Mar 1;171(3):230-238
pubmed: 28114647
J Commun Disord. 2000 Jul-Aug;33(4):321-31; quiz 332
pubmed: 11001159
J Child Neurol. 2017 May;32(6):550-559
pubmed: 28424004
Pediatrics. 2009 Aug;124(2):590-5
pubmed: 19651581
Pediatrics. 2007 Sep;120(3):609-16
pubmed: 17766535
Stroke. 2012 Jun;43(6):1602-8
pubmed: 22474056
J Pediatr. 2011 Sep;159(3):466-471.e1
pubmed: 21429505
Dev Med Child Neurol. 2007 Aug;49(8):564
pubmed: 17635196
Lancet Child Adolesc Health. 2018 Sep;2(9):666-676
pubmed: 30119760
Pediatr Neurol. 2006 Sep;35(3):197-203
pubmed: 16939860
Pediatrics. 2008 Jun;121(6):e1534-40
pubmed: 18519457
Dev Med Child Neurol. 2014 Jun;56(6):516-21
pubmed: 24528276
Early Hum Dev. 2009 May;85(5):279-84
pubmed: 19141366
J Neuroeng Rehabil. 2017 Feb 15;14(1):13
pubmed: 28202036
Stroke. 2019 Feb;50(2):233-239
pubmed: 30661493
J Pediatr. 2010 Jun;156(6):907-913.e2
pubmed: 20304425
Stroke. 2013 Nov;44(11):3265-71
pubmed: 24105698
Eur J Paediatr Neurol. 2019 Jan;23(1):31-42
pubmed: 30446273
Pediatr Res. 2005 Aug;58(2):302-8
pubmed: 16006434
Pediatrics. 1987 May;79(5):706-12
pubmed: 3575026
Hum Brain Mapp. 2017 May;38(5):2424-2440
pubmed: 28176425
Neurorehabil Neural Repair. 2016 Sep;30(8):762-72
pubmed: 26747126
Pediatr Neurol. 2013 Feb;48(2):81-94
pubmed: 23337000
Ann Neurol. 2008 Apr;63(4):436-43
pubmed: 18306227

Auteurs

Amanda Leong (A)

Calgary Pediatric Stroke Program, Alberta Children's Hospital, Calgary, Alberta, Canada.

Amalia Floer (A)

Calgary Pediatric Stroke Program, Alberta Children's Hospital, Calgary, Alberta, Canada.

Adam Kirton (A)

Calgary Pediatric Stroke Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
Department of Pediatrics and Clinical Neurosciences, Alberta Children's Hospital, Calgary, Alberta, Canada.

Aleksandra Mineyko (A)

Calgary Pediatric Stroke Program, Alberta Children's Hospital, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH